More top stories
ARDANA, the Edinburgh-based biotech firm which employs around 30 staff, is seeking to either sell itself or secure a merger to allow it to maximise the value of its sales and product pipeline.
RISING production of biofuels is driving up food prices, one of the government's top scientific advisers warned yesterday.
SCOTLAND'S life sciences sector might struggle to fill the 500-plus jobs promised by the creation of the £59 million Scottish Centre for Regenerative Medicine (SCRM), a leading biotech recruitment consultant has claimed.
INVITROGEN, the US biotechnology giant, has confirmed plans to sell its BioReliance drug services division, which employs about 300 scientists in Scotland, for less than half what it paid for the business three years ago.
INVITROGEN, the US biotechnology giant, is understood to be drawing up plans to sell its BioReliance drug services division which it acquired for £275m three years ago.
SCOTLAND'S rush to commercialise medical research is putting the industry's long-term interests at risk, a senior academic has warned.
SIPPING an espresso in the lobby of the Edinburgh International Conference Centre, Aisling Burnand does not look like a bruiser. But the chief executive of the BioIndustry Association has been fighting on at least three fronts over the past year and is not ready to give up.
STEM Cell Sciences said it had clocked up "significant progress" in developing its business plan over 2006 and predicted strong growth in revenues this year on the back of a string of recent licensing deals.
LIFE sciences giant Invitrogen has scrapped a plan to build a £17 million global business base at European headquarters in Renfrewshire, according to deleted minutes posted on Scottish Enterprise's website.
STEM Cell Sciences, the Edinburgh-based biotechnology company, has announced that it has secured "material transfer" and "option to license" agreements to explore the use of L-particles and PREPS technology owned by drug discoverer Henderson Morley.
WHO should decide what the limits are for science? That's the question raised by the Government's proposed revisions of the 1990 Human Fertilisation and Embryology Act, published last month.
A LEADING life sciences expert said the collapse of PPL Therapeutics, creator of Dolly the cloned sheep, "severely dented" Scotland's biotech industry.
ITI Life Sciences has reached a milestone with the signing of commercialisation licences with CXR Biosciences of Dundee and Artemis Pharmaceuticals of Cologne. The licences will allow both companies to commercialise new technology.
BIOTECHNOLOGY is of "fundamental importance" to the UK economy, Tony Blair said in San Francisco last night.
LOTHIAN biomedical firm Lab901 has won £1.5 million of funding to help commercialise the "tape" technology it has developed to speed up DNA testing.
DRUGS giant AstraZeneca is to acquire one of the UK's biggest biotechnology groups in a deal worth £702 million.
NANOSCIENCE and nanotechnology involve studying and working with matter on an ultra-small scale. One nanometre is one-millionth of a millimetre and a single human hair is around 80,000 nanometres in width.
Key quote "The technology and applications of nanoparticles are racing ahead and still we haven't actually put together a proper research programme into the effect of nanoparticles on the biological system." - Professor Anthony Seaton